Finding 572590 (2024-001)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2024
Accepted
2025-08-05
Audit: 363723
Organization: Substance Abuse Services, Inc. (PA)

AI Summary

  • Core Issue: Missing approved source documentation for a recurring expense related to the Opioid STR Grant.
  • Impacted Requirements: Lack of compliance with CFR 200.302(b)(3), which mandates proper record-keeping for federal funds.
  • Recommended Follow-Up: Ensure all expenses charged to federal grants have supporting documentation and management approval, and implement a filing policy for better document management.

Finding Text

#2024‐001 – Significant Deficiency – Supporting Documentation Opioid STR Grant ALN 93.788 Criteria The Office of Management and Budget issuance of the Code of Federal Regulations (CFR) specifically states uniform administrative requirements, cost principles, and audit requirements for federal awards. CFR 200.302(b)(3) states, “The recipient’s financial management system must maintain records that sufficiently identify the amount, source, and expenditure of Federal funds for Federal awards. These records must contain information necessary to identify Federal awards, authorizations, financial obligations, unobligated balances, as well as assets, expenditures, income, and interest. All records must be supported by source documentation.” Condition During the course of the audit, we noted there was no approved source documentation for a recurring expense tested. Cause The Organization has made a reasonable effort to design proper controls, but has faced challenges in implementing them effectively, due to growth across multiple locations and frequent turnover. Effect The potential effects of not having supporting documentation on file could include over or undercharging expenses to the federal grants. Questioned Costs None Perspective Information The finding noted related to one (1) transaction examined when testing a sample of forty (40) non‐payroll cash disbursements. The transaction was a recurring monthly charge that was supported by an agreement approved by an employee who has since left the Organization. The Organization was unable to locate a copy of the signed agreement. Identification as a repeat finding There was no similar finding in the prior year. Recommendation We recommend having supporting documentation on file for all expenses charged to the Federal grants that shows approval of the expense from an appropriate member of management. View of Responsible Official The CEO has implemented a policy that all signed documents and contracts will be uniformly kept in a corresponding file, and the files will be stored in a locked filing cabinet at the corporate office. The Director of Operations will be responsible to ensure that the documents and contracts are filed in a timely fashion.

Corrective Action Plan

View of Responsible Official The CEO has implemented a policy that all signed documents and contracts will be uniformly kept in a corresponding file, and the files will be stored in a locked filing cabinet at the corporate office. The Director of Operations will be responsible to ensure that the documents and contracts are filed in a timely fashion.

Categories

Allowable Costs / Cost Principles Significant Deficiency

Other Findings in this Audit

  • 572591 2024-001
    Significant Deficiency
  • 572592 2024-001
    Significant Deficiency
  • 572593 2024-001
    Significant Deficiency
  • 572594 2024-001
    Significant Deficiency
  • 572595 2024-001
    Significant Deficiency
  • 572596 2024-002
    Significant Deficiency Repeat
  • 572597 2024-002
    Significant Deficiency Repeat
  • 572598 2024-002
    Significant Deficiency Repeat
  • 572599 2024-002
    Significant Deficiency Repeat
  • 572600 2024-002
    Significant Deficiency Repeat
  • 572601 2024-002
    Significant Deficiency Repeat
  • 1149032 2024-001
    Significant Deficiency
  • 1149033 2024-001
    Significant Deficiency
  • 1149034 2024-001
    Significant Deficiency
  • 1149035 2024-001
    Significant Deficiency
  • 1149036 2024-001
    Significant Deficiency
  • 1149037 2024-001
    Significant Deficiency
  • 1149038 2024-002
    Significant Deficiency Repeat
  • 1149039 2024-002
    Significant Deficiency Repeat
  • 1149040 2024-002
    Significant Deficiency Repeat
  • 1149041 2024-002
    Significant Deficiency Repeat
  • 1149042 2024-002
    Significant Deficiency Repeat
  • 1149043 2024-002
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $34,153
93.788 Opioid Str $18,999
93.279 Drug Use and Addiction Research Programs $11,032
93.959 Block Grants for Prevention and Treatment of Substance Abuse $1,980